Acquisition Opportunity The Dunn Group was acquired by SAI MedPartners, signaling a potential integration point for ongoing competitive intelligence services, post‑acquisition expansion plans, and cross-sell opportunities with SAI’s broader life sciences portfolio.

Market Expansion As a global leader in life sciences intelligence serving pharmaceuticals, biotech, diagnostics, and medical devices, TDG has a broad addressable market for expanding into related sectors and geographies through enhanced intelligence solutions.

Growth Readiness Revenue range of $10M‑$25M with 11‑50 employees indicates a mid‑market profile that is often receptive to scalable, subscription or retainer based intelligence services, training, and tailored market insights.

Tech Enablement Current tech stack includes web and UI tooling (Open Graph, RequireJS, TweenMax, Lightbox, reCAPTCHA) suggesting opportunities to upsell advanced data analytics platforms, dashboards, and secure client portals for intelligence delivery.

Competitive Positioning As a trusted BI provider with a global focus in life sciences, there are cross‑sell opportunities with large corporate buyers in the engineering‑adjacent services space and potential partnerships or channel strategies leveraging SAI MedPartners’ network.